Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Urinary Bladder Neoplasms 30Carcinoma, Renal Cell 17Prostatic Neoplasms 13Carcinoma, Transitional Cell 11Melanoma 8Carcinoma, Non-Small-Cell Lung 7Breast Neoplasms 7Uterine Cervical Neoplasms 6Kidney Neoplasms 6Non-Muscle Invasive Bladder Neoplasms 5Triple Negative Breast Neoplasms 4Small Cell Lung Carcinoma 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Neoplasm Metastasis 4Colorectal Neoplasms 4Carcinoma, Merkel Cell 4Squamous Cell Carcinoma of Head and Neck 3Head and Neck Neoplasms 3Carcinoma, Hepatocellular 3Urothelial Cancer 2Testicular Neoplasms 2Stomach Neoplasms 2Neoplasms 2Lung Neoplasms 2Hodgkin Disease 2Esophageal Neoplasms 2Endometrial Neoplasms 2Carcinoma in Situ 2Carcinoma 2

Interventions

pembrolizumab 3Nivolumab 3atezolizumab 2fludarabine 1epacadostat 1durvalumab 1avelumab 1aldesleukin 1Interleukin-2 1Docetaxel 1Cyclophosphamide 1Carboxylesterase 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Microsatellite Instability × durvalumab × Genitourinary × Clear all
NCT03228667 2026-01-14

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

ImmunityBio, Inc.

Phase 2 Active not recruiting
40 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Melanoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Microsatellite Instability, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡